No Data
No Data
Express News | GlaxoSmithKline and curevac have redrafted their mRNA vaccine collaboration agreement
Sector Update: Health Care
Health care stocks were advancing pre-bell Wednesday, with the Health Care Select Sector SPDR Fund (XLV) up 0.1% and the iShares Biotechnology ETF (IBB) was nearly 18% higher recently. CureVac (CVAC)
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Wednesday Ahead of Economic Data Deluge
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was flat and the actively traded Invesco QQQ Trust (QQQ) was 0.03% lower in Wednesday's premarket activity as markets traded mixed ah
GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
Wednesday, GSK plc (NYSE:GSK) and CureVac N.V. (NASDAQ:CVAC) announced they have restructured their existing collaboration into a new licensing agreement, allowing the companies to prioritize investme
GSK to Buy CureVac's Covid-19, Flu Vaccine Rights for Up to $1.56 Bln
GSK struck a deal to buy the rights to CureVac's Covid-19 and flu vaccines for up to 1.45 billion euros ($1.56 billion), in a bid to regain ground lost to newcomers to the vaccine market during the pandemic.
Update: Market Chatter: Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits
(Updates with statement from GSK in fourth and fifth paragraphs.) A Delaware Superior Court judge rejected an appeal from GSK (GSK) and other drugmakers to overturn a ruling that cleared the way for o